Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Adipostatins A-D from Streptomyces sp. 4875 inhibiting Brugia malayi asparaginyl-tRNA synthetase and killing adult Brugia malayi parasites.

Rateb ME, Yang D, Vodanovic-Jankovic S, Yu Z, Kron MA, Shen B.

J Antibiot (Tokyo). 2015 Aug;68(8):540-2. doi: 10.1038/ja.2015.22. Epub 2015 Mar 4. No abstract available.

PMID:
25735843
2.

Medium optimization of Streptomyces sp. 17944 for tirandamycin B production and isolation and structural elucidation of tirandamycins H, I and J.

Rateb ME, Yu Z, Yan Y, Yang D, Huang T, Vodanovic-Jankovic S, Kron MA, Shen B.

J Antibiot (Tokyo). 2014 Jan;67(1):127-32. doi: 10.1038/ja.2013.50. Epub 2013 May 29.

3.

Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis.

Kron MA, Metwali A, Vodanovic-Jankovic S, Elliott D.

Clin Vaccine Immunol. 2013 Feb;20(2):276-81. doi: 10.1128/CVI.00594-12. Epub 2012 Dec 19.

4.

New WS9326A congeners from Streptomyces sp. 9078 inhibiting Brugia malayi asparaginyl-tRNA synthetase.

Yu Z, Vodanovic-Jankovic S, Kron M, Shen B.

Org Lett. 2012 Sep 21;14(18):4946-9. Epub 2012 Sep 12.

5.

Interleukin-8-like activity in a filarial asparaginyl-tRNA synthetase.

Kron MA, Wang C, Vodanovic-Jankovic S, Howard OM, Kuhn LA.

Mol Biochem Parasitol. 2012 Sep;185(1):66-9. doi: 10.1016/j.molbiopara.2012.06.003. Epub 2012 Jun 16.

PMID:
22710390
6.

Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase.

Yu Z, Vodanovic-Jankovic S, Ledeboer N, Huang SX, Rajski SR, Kron M, Shen B.

Org Lett. 2011 Apr 15;13(8):2034-7. doi: 10.1021/ol200420u. Epub 2011 Mar 15.

7.

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR.

Blood. 2007 Nov 15;110(10):3804-13. Epub 2007 Aug 10.

8.

Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment.

Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR.

Blood. 2007 Jun 15;109(12):5502-10. Epub 2007 Mar 8.

9.
10.

NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

Vodanovic-Jankovic S, Hari P, Jacobs P, Komorowski R, Drobyski WR.

Blood. 2006 Jan 15;107(2):827-34. Epub 2005 Sep 20.

11.

Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.

Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR.

J Immunol. 2004 Mar 1;172(5):3328-36.

12.

Elimination of leukemia in the absence of lethal graft-versus-host disease after allogenic bone marrow transplantation.

Drobyski WR, Gendelman M, Vodanovic-Jankovic S, Gorski J.

J Immunol. 2003 Mar 15;170(6):3046-53.

13.

Supplemental Content

Loading ...
Support Center